Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: A possible role of Hepatitis B virus

Annals of Surgical Oncology

Volumn 18, Issue 5, 2011, Pages 1258-1266

  Peng, Ning Fu ^a   Li, Le Qun ^b   Qin, Xiao ^a   Guo, Ya ^a   Peng, Tao ^a   Xiao, Kai Yin ^a   Chen, Xi Gang ^a   Yang, Yu Feng ^c   Su, Zhi Xiong ^a   Chen, Bin ^a   Su, Ming ^a   Qi, Lu Nan ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b GUANGXI MEDICAL UNIVERSITY   (China)

^c Shilong People's Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT STONE; CELL INFILTRATION; CHINA; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL; NONHUMAN; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; BILE DUCT NEOPLASMS; CASE-CONTROL STUDIES; CHINA; CHOLANGIOCARCINOMA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79955812260     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1458-5     Document Type: Article

References (49)

1. T Ben-Menachem 2007 Risk factors for cholangiocarcinoma Eur J Gastroenterol Hepatol 19 615 617 17625428 10.1097/MEG.0b013e328224b935 (Pubitemid 47067057)
2. B Blechacz GJ Gores 2008 Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment Hepatology 48 308 321 18536057 10.1002/hep.22310 1:CAS:528:DC%2BD1cXptFemu70%3D (Pubitemid 351975555)
3. SA Khan SD Taylor-Robinson MB Toledano, et al. 2002 Changing international trends in mortality rates for liver, biliary and pancreatic tumours J Hepatol 37 806 813 12445422 10.1016/S0168-8278(02)00297-0 (Pubitemid 35404220)
4. TM Welzel KA McGlynn AW Hsing TR O'Brien RM Pfeiffer 2006 Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States J Natl Cancer Inst 98 873 875 16788161 10.1093/jnci/djj234 (Pubitemid 43923444)
5. KA McGlynn RE Tarone HB El-Serag 2006 A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States Cancer Epidemiol Biomarkers Prev 15 1198 1203 16775181 10.1158/1055-9965.EPI-05-0811
6. WL Wang GY Gu M Hu 1998 Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma World J Gastroenterol 4 392 396 11819329 1:CAS:528:DyaK1MXht1Glsbc%3D (Pubitemid 128620198)
7. S Yamamoto S Kubo S Hai, et al. 2004 Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma Cancer Sci 95 592 595 15245596 10.1111/j.1349-7006.2004.tb02492.x 1:CAS:528:DC%2BD2cXnt1WjsbY%3D (Pubitemid 39089641)
8. V Perumal J Wang P Thuluvath M Choti M Torbenson 2006 Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States Hum Pathol 37 1211 1216 16938527 10.1016/j.humpath.2006.04.012 1:CAS:528:DC%2BD28XovVWrt7g%3D (Pubitemid 44286989)
9. TM Welzel BI Graubard HB El-Serag, et al. 2007 Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study Clin Gastroenterol Hepatol 5 1221 1228 17689296 10.1016/j.cgh.2007.05.020 (Pubitemid 47496233)
10. CH Lee CJ Chang YJ Lin, et al. 2009 Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma Br J Cancer 100 1765 1770 19436294 10.1038/sj.bjc. 6605063 1:STN:280:DC%2BD1Mvgt1Cgtw%3D%3D
11. H Zhou H Wang D Zhou, et al. 2010 Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis Eur J Cancer 46 1056 1061 20202823 10.1016/j.ejca.2010.02.005 1:CAS:528:DC%2BC3cXjs1alt7c%3D
12. S Tanaka T Yamamoto H Tanaka, et al. 2005 Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: immunohistochemical evidence Hepatol Res 32 52 57 15888382 10.1016/j.hepres.2005.01.012 1:CAS:528:DC%2BD2MXlt1Khu7c%3D (Pubitemid 40823317)
13. T Roskams 2006 Liver stem cells and their implication in hepatocellular and cholangiocarcinoma Oncogene 25 3818 3822 16799623 10.1038/sj.onc.1209558 1:CAS:528:DC%2BD28XmtFCntLs%3D (Pubitemid 43980477)
14. F Zhang XP Chen W Zhang, et al. 2008 Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence Histopathology 52 224 232 18184271 10.1111/j.1365-2559.2007.02929.x 1:STN:280:DC%2BD1c%2Fit1aqtg%3D%3D
15. SC Hadler BL Murphy CA Schable, et al. 1984 Epidemiological analysis of the significance of low-positive test results for antibody to hepatitis B surface and core antigens J Clin Microbiol 19 521 525 6715519 1:STN:280:DyaL2c7os1Squg%3D%3D (Pubitemid 14161861)
16. Liver Cancer Study Group of Japan. Intrahepatic cholangiocarcinoma, macroscopic typing. In: Okamoto E, eds. Classification of Primary Liver Cancer. Tokyo: Kanehara, 1997:6-7.
17. SH Yu M Kawanaka XM Li, et al. 2003 Epidemiological investigation on Clonorchis sinensis in human population in an area of South China Jpn J Infect Dis 56 168 171 14583642 (Pubitemid 37456070)
18. R Lin X Li C Lan S Yu M Kawanaka 2005 Investigation on the epidemiological factors of Clonorchis sinensis infection in an area of south China Southeast Asian J Trop Med Public Health 36 1114 1117 16438134 (Pubitemid 43058827)
19. J Zhuo G Tao SH Ebrahim, et al. 2000 The relationship of hepatitis B virus infection between adults and their children in Guangxi Province, China J Hepatol 33 628 631 11059868 10.1034/j.1600-0641.2000.033004628.x 1:STN:280:DC%2BD3crgvVSltg%3D%3D
20. FS Yeh MC Yu CC Mo, et al. 1989 Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China Cancer Res 49 2506 2509 2539905 1:STN:280:DyaL1M3gvVGktQ%3D%3D (Pubitemid 19125586)
21. CR Marrero JA Marrero 2007 Viral hepatitis and hepatocellular carcinoma Arch Med Res 38 612 620 17613352 10.1016/j.arcmed.2006.09.004 1:CAS:528:DC%2BD2sXnsFKhu7k%3D (Pubitemid 47001566)
22. C Berasain J Castillo MJ Perugorria, et al. 2009 Inflammation and liver cancer: new molecular links Ann N Y Acad Sci 1155 206 221 19250206 10.1111/j.1749-6632.2009.03704.x 1:CAS:528:DC%2BD1MXktFKltrk%3D
23. N De Alwis G Hudson AD Burt CP Day PF Chinnery 2009 Human liver stem cells originate from the canals of Hering Hepatology 50 992 993 19714715 10.1002/hep.23160
24. E Gaudio G Carpino V Cardinale, et al. 2009 New insights into liver stem cells Dig Liver Dis 41 455 462 19403350 10.1016/j.dld.2009.03.009 1:CAS:528:DC%2BD1MXht1KitL%2FP
25. TG Fellous S Islam PJ Tadrous, et al. 2009 Locating the stem cell niche and tracing hepatocyte lineages in human liver Hepatology 49 1655 1663 19309719 10.1002/hep.22791 1:CAS:528:DC%2BD1MXlslKmu7k%3D
26. V Bhagat M Javle J Yu, et al. 2006 Combined hepatocholangiocarcinoma: case-series and review of literature Int J Gastrointest Cancer 37 27 34 17290078 10.1385/IJGC:37:1:27
27. K Inaba S Suzuki T Sakaguchi, et al. 2007 Double primary liver cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis J Hepatobiliary Pancreat Surg 14 204 209 17384916 10.1007/s00534-006-1134-0 (Pubitemid 46502152)
28. F Chen S Li V Castranova 2009 Overlapping signature genes between hepatocellular carcinoma and intrahepatic cholangiocarcinoma Eur J Gastroenterol Hepatol 21 1320 1321 19826380 10.1097/MEG.0b013e32832b2123
29. J Wands 2007 Hepatocellular carcinoma and sex N Engl J Med 357 1974 1976 17989393 10.1056/NEJMcibr075652 1:CAS:528:DC%2BD2sXht1ymtbbP (Pubitemid 350074697)
30. N Wang Y Zheng X Yu, et al. 2009 Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer Am J Epidemiol 169 990 995 19224979 10.1093/aje/kwn418
31. BT Spear 1999 Alpha-fetoprotein gene regulation: lessons from transgenic mice Semin Cancer Biol 9 109 116 10202132 10.1006/scbi.1998.0087 1:CAS:528:DyaK1MXitlSmurg%3D (Pubitemid 29265526)
32. T Ishii K Yasuchika H Fujii, et al. 2005 In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes Exp Cell Res 309 68 77 16009362 10.1016/j.yexcr.2005.05.028 1:CAS:528:DC%2BD2MXpt1ektbg%3D (Pubitemid 41191224)
33. T Ishii K Fukumitsu K Yasuchika, et al. 2008 Effects of extracellular matrixes and growth factors on the hepatic differentiation of human embryonic stem cells Am J Physiol Gastrointest Liver Physiol 295 G313 G321 18535293 10.1152/ajpgi.00072.2008 1:CAS:528:DC%2BD1cXhtVaktrnJ
34. Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 1990;211:277-87.
35. K Ishikawa A Sasaki N Haraguchi Y Yoshikawa M Mori 2007 A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin Oncologist 12 320 324 17405896 10.1634/theoncologist.12- 3-320 1:CAS:528:DC%2BD2sXlsVSqtbk%3D (Pubitemid 46556798)
36. T Ishii K Yasuchika H Suemori, et al. 2010 Alpha-fetoprotein producing cells act as cancer progenitor cells in human cholangiocarcinoma Cancer Lett 294 25 34 20149523 10.1016/j.canlet.2010.01.019 1:CAS:528:DC%2BC3cXmtlyitb4%3D
37. M Yamamoto S Ariizumi T Otsubo, et al. 2004 Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma J Surg Oncol 87 80 83 15282700 10.1002/jso.20091 (Pubitemid 39079653)
38. M Sasaki K Tsuneyama A Ishikawa Y Nakanuma 2003 Intrahepatic cholangiocarcinoma in cirrhosis presents granulocyte and granulocyte-macrophage colony-stimulating factor Hum Pathol 34 1337 1344 14691921 10.1016/j.humpath. 2003.07.012 1:CAS:528:DC%2BD3sXhtVShsrfK (Pubitemid 38018149)
39. Y Nakanuma M Sasaki H Ikeda, et al. 2008 Pathology of peripheral intrahepatic cholangiocarcinoma with reference to tumorigenesis Hepatol Res 38 325 334 18093122 10.1111/j.1872-034X.2007.00312.x (Pubitemid 351321174)
40. N Yamanaka E Okamoto T Ando, et al. 1995 Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma Cancer 76 2449 2456 8625070 10.1002/1097-0142(19951215)76:12<2449::AID-CNCR2820761208>3. 0.CO;2-V 1:STN:280:DyaK283itlejtw%3D%3D
41. K Shirabe M Shimada N Harimoto, et al. 2002 Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities Surgery 131 S159 S164 11821804 10.1067/msy.2002.119498 (Pubitemid 34118633)
42. XD Zhou ZY Tang J Fan, et al. 2009 Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5, 829 patients with hepatocellular carcinoma J Cancer Res Clin Oncol 135 1073 1080 19294418 10.1007/s00432-009- 0547-y
43. S Isaji Y Kawarada H Taoka, et al. 1999 Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 6 108 116 10398896 10.1007/s005340050092 1:STN:280:DyaK1MzivFemuw%3D%3D
44. K Shimada T Sano Y Sakamoto, et al. 2007 Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma World J Surg 31 2016 2022 17687597 10.1007/s00268-007-9194-0 (Pubitemid 47415732)
45. A Sasaki M Aramaki K Kawano, et al. 1998 Intrahepatic peripheral cholangiocarcinoma: mode of spread and choice of surgical treatment Br J Surg 85 1206 1209 9752860 10.1046/j.1365-2168.1998.00815.x 1:STN:280: DyaK1cvitlOrsA%3D%3D (Pubitemid 28430419)
46. KQ Hu 2002 Occult hepatitis B virus infection and its clinical implications J Viral Hepat 9 243 257 12081601 10.1046/j.1365-2893.2002.00344.x (Pubitemid 36002459)
47. M Torbenson DL Thomas 2002 Occult hepatitis B Lancet Infect Dis 2 479 486 12150847 10.1016/S1473-3099(02)00345-6 (Pubitemid 34826853)
48. I Chemin C Trepo 2005 Clinical impact of occult HBV infections J Clin Virol 34 Suppl 1 S15 S21 16461218 10.1016/S1386-6532(05)80005-8 (Pubitemid 43197745)
49. J Lupberger E Hildt 2007 Hepatitis B virus-induced oncogenesis World J Gastroenterol 13 74 81 17206756 1:CAS:528:DC%2BD2sXitFSgt7g%3D (Pubitemid 46165464)